FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382632023> ?p ?o ?g. }

• W4382632023 abstract "Clinical trial design must consider the specific resource constraints and overall goals of the drug development process (DDP); for example, in designing a phase I trial to evaluate the safety of a drug and recommend a dose for a subsequent phase II trial. Here, we focus on design considerations that involve the sequence of clinical trials, from early phase I to late phase III, that constitute the DDP.We discuss how stylized simulation models of clinical trials in an oncology DDP can quantify important relationships between early-phase trial designs and their consequences for the remaining phases of development. Simulations for three illustrative settings are presented, using stylized models of the DDP that mimic trial designs and decisions, such as the potential discontinuation of the DDP.We describe: (1) the relationship between a phase II single-arm trial sample size and the likelihood of a positive result in a subsequent phase III confirmatory trial; (2) the impact of a phase I dose-finding design on the likelihood that the DDP will produce evidence of a safe and effective therapy; and (3) the impact of a phase II enrichment trial design on the operating characteristics of a subsequent phase III confirmatory trial.Stylized models of the DDP can support key decisions, such as the sample size, in the design of early-phase trials. Simulation models can be used to estimate performance metrics of the DDP under realistic scenarios; for example, the duration and the total number of patients enrolled. These estimates complement the evaluation of the operating characteristics of early-phase trial design, such as power or accuracy in selecting safe and effective dose levels." @default.
• W4382632023 created "2023-07-01" @default.
• W4382632023 creator A5015287155 @default.
• W4382632023 creator A5017597821 @default.
• W4382632023 creator A5075153453 @default.
• W4382632023 creator A5084581258 @default.
• W4382632023 date "2023-06-29" @default.
• W4382632023 modified "2023-10-09" @default.
• W4382632023 title "Looking ahead in early-phase trial design to improve the drug development process: examples in oncology" @default.
• W4382632023 cites W1965187690 @default.
• W4382632023 cites W2024963690 @default.
• W4382632023 cites W2032783186 @default.
• W4382632023 cites W2046081213 @default.
• W4382632023 cites W2054383376 @default.
• W4382632023 cites W2076108528 @default.
• W4382632023 cites W2112816227 @default.
• W4382632023 cites W2113344831 @default.
• W4382632023 cites W2118782378 @default.
• W4382632023 cites W2129546350 @default.
• W4382632023 cites W2150692855 @default.
• W4382632023 cites W2223585524 @default.
• W4382632023 cites W2470227280 @default.
• W4382632023 cites W2617077704 @default.
• W4382632023 cites W2766503825 @default.
• W4382632023 cites W2791377051 @default.
• W4382632023 cites W2793750722 @default.
• W4382632023 cites W2801395530 @default.
• W4382632023 cites W2805734855 @default.
• W4382632023 cites W2885447570 @default.
• W4382632023 cites W2897697239 @default.
• W4382632023 cites W2904154481 @default.
• W4382632023 cites W2948259519 @default.
• W4382632023 cites W2948551797 @default.
• W4382632023 cites W2973459418 @default.
• W4382632023 cites W2983623050 @default.
• W4382632023 cites W2989861603 @default.
• W4382632023 cites W3035123324 @default.
• W4382632023 cites W3091096390 @default.
• W4382632023 cites W3095107109 @default.
• W4382632023 cites W3100720535 @default.
• W4382632023 cites W3157645496 @default.
• W4382632023 cites W3165444463 @default.
• W4382632023 cites W3166593234 @default.
• W4382632023 cites W3169629379 @default.
• W4382632023 cites W3186806797 @default.
• W4382632023 doi "https://doi.org/10.1186/s12874-023-01979-5" @default.
• W4382632023 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37386450" @default.
• W4382632023 hasPublicationYear "2023" @default.
• W4382632023 type Work @default.
• W4382632023 citedByCount "0" @default.
• W4382632023 crossrefType "journal-article" @default.
• W4382632023 hasAuthorship W4382632023A5015287155 @default.
• W4382632023 hasAuthorship W4382632023A5017597821 @default.
• W4382632023 hasAuthorship W4382632023A5075153453 @default.
• W4382632023 hasAuthorship W4382632023A5084581258 @default.
• W4382632023 hasBestOaLocation W43826320231 @default.
• W4382632023 hasConcept C105795698 @default.
• W4382632023 hasConcept C126322002 @default.
• W4382632023 hasConcept C129848803 @default.
• W4382632023 hasConcept C139719470 @default.
• W4382632023 hasConcept C143998085 @default.
• W4382632023 hasConcept C148482608 @default.
• W4382632023 hasConcept C162324750 @default.
• W4382632023 hasConcept C178790620 @default.
• W4382632023 hasConcept C185592680 @default.
• W4382632023 hasConcept C19527891 @default.
• W4382632023 hasConcept C2778715236 @default.
• W4382632023 hasConcept C2779318504 @default.
• W4382632023 hasConcept C2780035454 @default.
• W4382632023 hasConcept C33923547 @default.
• W4382632023 hasConcept C38935604 @default.
• W4382632023 hasConcept C41008148 @default.
• W4382632023 hasConcept C44280652 @default.
• W4382632023 hasConcept C535046627 @default.
• W4382632023 hasConcept C64903051 @default.
• W4382632023 hasConcept C71924100 @default.
• W4382632023 hasConcept C98274493 @default.
• W4382632023 hasConceptScore W4382632023C105795698 @default.
• W4382632023 hasConceptScore W4382632023C126322002 @default.
• W4382632023 hasConceptScore W4382632023C129848803 @default.
• W4382632023 hasConceptScore W4382632023C139719470 @default.
• W4382632023 hasConceptScore W4382632023C143998085 @default.
• W4382632023 hasConceptScore W4382632023C148482608 @default.
• W4382632023 hasConceptScore W4382632023C162324750 @default.
• W4382632023 hasConceptScore W4382632023C178790620 @default.
• W4382632023 hasConceptScore W4382632023C185592680 @default.
• W4382632023 hasConceptScore W4382632023C19527891 @default.
• W4382632023 hasConceptScore W4382632023C2778715236 @default.
• W4382632023 hasConceptScore W4382632023C2779318504 @default.
• W4382632023 hasConceptScore W4382632023C2780035454 @default.
• W4382632023 hasConceptScore W4382632023C33923547 @default.
• W4382632023 hasConceptScore W4382632023C38935604 @default.
• W4382632023 hasConceptScore W4382632023C41008148 @default.
• W4382632023 hasConceptScore W4382632023C44280652 @default.
• W4382632023 hasConceptScore W4382632023C535046627 @default.
• W4382632023 hasConceptScore W4382632023C64903051 @default.
• W4382632023 hasConceptScore W4382632023C71924100 @default.
• W4382632023 hasConceptScore W4382632023C98274493 @default.
• W4382632023 hasIssue "1" @default.
• W4382632023 hasLocation W43826320231 @default.

• next